Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.19), $0.36 better than the analyst estimate of ($1.55). Revenue for the quarter came in at $40.41 million versus the consensus estimate of $11.28 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.